Publication:
Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report Authors

Simple item page
creativeworkseries.issnJNMA Print ISSN: 0028-2715; Online ISSN: 1815-672X
dc.contributor.authorBasnet, Angela
dc.contributor.authorOjha, Shiva Kumar
dc.contributor.authorJha, Suman Kumar
dc.contributor.authorPaudyal, Anjana
dc.contributor.authorKhadka, Manoj
dc.contributor.authorKhadka, Manita
dc.contributor.authorShrestha, Dhan Bahadur
dc.date.accessioned2026-02-20T07:23:57Z
dc.date.available2026-02-20T07:23:57Z
dc.date.issued2021
dc.descriptionAngela Basnet Department of Internal Medicine, Scheer Memorial Adventist Hospital, Banepa, Kavrepalanchok, Nepal https://orcid.org/0000-0002-0760-6510 Shiva Kumar Ojha Department of Internal Medicine, Scheer Memorial Adventist Hospital, Banepa, Kavrepalanchok, Nepal https://orcid.org/0000-0003-4248-4114 Suman Kumar Jha Department of Internal Medicine, Scheer Memorial Adventist Hospital, Banepa, Kavrepalanchok, Nepal https://orcid.org/0000-0003-4629-4238 Anjana Paudyal Department of Internal Medicine, Scheer Memorial Adventist Hospital, Banepa, Kavrepalanchok, Nepal Manoj Khadka Nepalese Army Institute of Health Sciences, Sanobharyang, Kathmandu, Nepal https://orcid.org/0000-0002-0449-9254 Manita Khadka Nepalese Army Institute of Health Sciences, Sanobharyang, Kathmandu, Nepal https://orcid.org/0000-0001-9263-2598 Dhan Bahadur Shrestha Department of Internal Medicine, Mount Sinai Hospital, Chicago, USA https://orcid.org/0000-0002-8121-083X
dc.description.abstractAbstract: Nepal started the COVID-19 vaccination on 27 January 2021 with AstraZeneca/Oxford Coronavirus Disease-19 AZD1222 (Covishield) vaccine to control the Coronavirus disease pandemic. The vaccine has a good safety profile, with cardiovascular complications being rare. Herein we report a rare case of cardiovascular complication following Covishield vaccination in a 33 years old female who had dizziness and elevated blood pressure immediately following vaccination and abnormal electrocardiogram showing T wave inversions followed by left bundle branch block. The patient was kept on observation, following which the blood pressure and electrocardiogram changes were normal by seven days. This cardiovascular complication following the vaccination demands further investigation into the adverse event of the vaccine. However, since the benefit of the vaccine outweighs the risk, World Health Organization has recommended the continuity of the vaccine as of now.
dc.identifierhttps://doi.org/10.31729/jnma.6454
dc.identifier.urihttps://hdl.handle.net/20.500.14572/4835
dc.language.isoen_US
dc.publisherNepal Medical Association
dc.subjectbundle-branch block
dc.subjectcase report
dc.subjectCOVID-19 vaccine
dc.subjectNepal
dc.titleCardiovascular Complication following Covishield Vaccination in Nepal: A Case Report Authors
dc.typeArticle
dspace.entity.typePublication
local.article.typeCase Report
oaire.citation.endPage807
oaire.citation.startPage805
relation.isJournalIssueOfPublication63b8b137-dbcc-4628-92ef-09baf080325d
relation.isJournalIssueOfPublication.latestForDiscovery63b8b137-dbcc-4628-92ef-09baf080325d
relation.isJournalOfPublicatione6e146a0-0ece-4aba-aa0a-6ccfbd10a12a

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
805-807.pdf
Size:
522.3 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Publications

Connect with us

Nepal Health Research Council © 2026
Ramshah Path, Kathmandu Nepal P.O.Box 7626